Medscape1d
Real-World Anifrolumab Use Shows Evidence of Long-Term Organ Damage Reduction in Lupus
Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...
Healio4d
‘Lupus does not universally burn out’: More than 35% of patients flare after dialysis
More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage ...
Medscape3d
Phase 2 Trial Supports TYK2 Inhibitor for Cutaneous Lupus, Paving Way for Pivotal Trials
After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...
Lupus Foundation of America1mon
New Study Highlights the Impact of Flares and Persistently Active Disease on Organ Damage in People with Systemic Lupus Erythematosus
A new study sought to identify the frequency and determinants of flares for with people with systemic lupus erythematosus (SLE) with persistently active disease (PAD). Researchers found that both ...
Physician's Weekly11d
Patients With Lupus at Risk for Recurrent Pericarditis
New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.
Nature15y
Lupus activation with cerebritis following pegylated interferon in a hemodialysis patient
Background. A 20-year-old female patient with chronic hepatitis C virus infection and end-stage renal disease due to systemic lupus erythematosus was admitted to hospital with fever, pain in the ...